Brain (and spinal cord) tumours
Results
Phase 1
This trial looked at nabiximols (Sativex) with temozolomide (Temodal) for a type of brain tumour called glioblastoma. It was for people whose cancer had come back after treatment.
This trial was open for people to join between 2013 and 2015. The team published the results in 2021.
Recruitment start: 25 September 2013
Recruitment end: 14 August 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Susan Short
Experimental Cancer Medicine Centre (ECMC)
GW Pharma
Last reviewed: 17 March 2023
CRUK internal database number: 11645